scholarly article | Q13442814 |
P50 | author | Finn Cilius Nielsen | Q30344758 |
Christian Godballe | Q44009330 | ||
Sören Möller | Q55030481 | ||
Jes Sloth Mathiesen | Q56994246 | ||
Ulla Feldt-Rasmussen | Q57422236 | ||
Kirstine Stochholm | Q58418397 | ||
P2093 | author name string | Maria Rossing | |
Kim Brixen | |||
Peter Vestergaard | |||
Anja Lisbeth Frederiksen | |||
Jens Bentzen | |||
Mette Gaustadnes | |||
Sten Schytte | |||
Åse Krogh Rasmussen | |||
Per Løgstrup Poulsen | |||
Jens Peter Kroustrup | |||
Christoffer Holst Hahn | |||
Henrik Baymler Pedersen | |||
P2860 | cites work | Choroidal metastases in multiple endocrine neoplasia type 2B | Q79629536 |
RET proto-oncogene in Sardinia: V804M is the most frequent mutation and may be associated with FMTC/MEN-2A phenotype | Q79814534 | ||
Novel Somatic RET Mutation Questioning the Causality of the RET I852M Germline Sequence Variant in Multiple Endocrine Neoplasia 2A | Q88230681 | ||
Molecular epidemiology of multiple endocrine neoplasia 2: implications for RET screening in the new millenium | Q30317941 | ||
Existing data sources for clinical epidemiology: Danish registries for studies of medical genetic diseases | Q30662801 | ||
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma | Q34468665 | ||
Epidemiology, clinical features, and genetics of multiple endocrine neoplasia type 2B in a complete population | Q34641074 | ||
Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility | Q34906650 | ||
Prevalence, incidence, and age at diagnosis in Marfan Syndrome | Q36344156 | ||
Medullary thyroid cancer: RET testing of an archival material | Q38419660 | ||
Risk Profile of the RET A883F Germline Mutation: An International Collaborative Study | Q38890175 | ||
Evidence for the founder effect of RET533 as the common Greek and Brazilian ancestor spreading multiple endocrine neoplasia 2A. | Q38991268 | ||
Medullary thyroid carcinoma and calcitonin | Q39357847 | ||
A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma | Q39613599 | ||
Distribution of RET Mutations in Multiple Endocrine Neoplasia 2 in Denmark 1994-2014: A Nationwide Study | Q40491580 | ||
Primary diagnosis of multiple pheochromocytomas in the brother of a MEN-2 patient by simultaneous MIBG scintigraphy and low-dose computed tomography | Q40603320 | ||
Calcitonin and PDN-21 as tumour markers in MEN-2 family screening for medullary thyroid carcinoma | Q42453110 | ||
Calcitonin gene-related peptide and calcitonin as tumour markers in MEN 2 family screening | Q42495031 | ||
Medullary thyroid cancer in Norway. A 30-year experience | Q42519787 | ||
Medullary thyroid cancer--screening | Q43662211 | ||
Medullary carcinoma of the thyroid gland. A review and report of 4 cases | Q44124502 | ||
The Danish Cancer Registry | Q45848855 | ||
Can measurement of basal calcitonin replace the pentagastrin test? | Q46305880 | ||
Founder Effect of the RETC611Y Mutation in Multiple Endocrine Neoplasia 2A in Denmark: A Nationwide Study | Q47819138 | ||
Multiple endocrine neoplasia type 2 RET protooncogene database: repository of MEN2-associated RET sequence variation and reference for genotype/phenotype correlations | Q48675067 | ||
Multiple endocrine neoplasia 2 in Cyprus: evidence for a founder effect | Q49356194 | ||
Screening for hereditary medullary cancer in Denmark | Q50553109 | ||
The Danish National Patient Register. | Q50554196 | ||
The Danish Pathology Register. | Q50554236 | ||
Incidence and prevalence of multiple endocrine neoplasia 2B in Denmark: a nationwide study. | Q50575214 | ||
[Medullary thyroid carcinoma in a 10-month-old child with multiple endocrine neoplasia 2B]. | Q54382356 | ||
Aggressive medullary thyroid carcinoma in a ten-year-old patient with multiple endocrine neoplasia 2B due to the A883F mutation. | Q55071074 | ||
Incidence and prevalence of sporadic and hereditary MTC in Denmark 1960-2014: a nationwide study. | Q55377929 | ||
Completeness and validity in a national clinical thyroid cancer database: DATHYRCA | Q60723964 | ||
Is thyroidectomy necessary in RET mutations carriers of the familial medullary thyroid carcinoma syndrome? | Q61757267 | ||
[Multiple endocrine neoplasia type 2a and 2b] | Q64050685 | ||
Calcitonin gene-related peptide and calcitonin in medullary thyroid carcinoma | Q68187805 | ||
Altered vitamin D metabolism and bone remodelling in patients with medullary thyroid carcinoma and hypercalcitoninemia | Q70459036 | ||
Familial medullary thyroid carcinoma in multiple endocrine neoplasia (MEN) IIa: diagnosis and problems in treatment | Q72536823 | ||
[Thyroid cancer in the county of North Jutland. Diagnosis, treatment and prognosis] | Q72794451 | ||
Calcitonin gene-related peptide in medullary thyroid carcinomas: characterization of molecular forms including the amidated C-terminus | Q72867393 | ||
Rapid MEN 2A gene carrier identification using primer-specific PCR amplification | Q73484361 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Denmark | Q35 |
multiple endocrine neoplasia | Q1553018 | ||
P304 | page(s) | 1479-1487 | |
P577 | publication date | 2018-10-12 | |
P1433 | published in | Clinical Epidemiology | Q5133758 |
P1476 | title | Incidence and prevalence of multiple endocrine neoplasia 2A in Denmark 1901-2014: a nationwide study | |
P478 | volume | 10 |